Combination therapy of non-small-cell lung carcinoma

摘要

Use of vitamin D analogues selected from tacalcitol and (lS,3R,5E,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5, 7,10(19),22-tetraen-1,3,24-triol (5,6-trans-calcipotriol) in combination with tyrosine kinase inhibitor imatinib in treatment of non-small cell lung cancer.